» Authors » Yukihiro Nishio

Yukihiro Nishio

Explore the profile of Yukihiro Nishio including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 31
Citations 417
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
21.
Ishiyama T, Sato K, Nishio Y, Saiki T, Miyaura N
Chem Commun (Camb) . 2005 Oct; (40):5065-7. PMID: 16220172
The aromatic C-H silylation of five-membered heteroarenes with 1,2-di-tert-butyl-1,1,2,2-tetrafluorodisilane regioselectively proceeded at 120 degrees C in octane in the presence of a catalytic amount of iridium(I) complexes generated from 1/2[Ir(OMe)(COD)]2...
22.
Mabuchi S, Ohmichi M, Nishio Y, Hayasaka T, Kimura A, Ohta T, et al.
Clin Cancer Res . 2004 Dec; 10(22):7645-54. PMID: 15569997
We investigated whether inhibition of nuclear factor-kappaB (NFkappaB) increases the efficacy of paclitaxel in in vitro and in vivo ovarian cancer models. Treatment of paclitaxel-sensitive Caov-3 cells with paclitaxel transiently...
23.
Kimura A, Ohmichi M, Kawagoe J, Kyo S, Mabuchi S, Takahashi T, et al.
Oncogene . 2004 Mar; 23(26):4505-15. PMID: 15048073
We examined the mechanism by which estrogen regulates telomerase activity in Caov-3 human ovarian cancer cell lines, which express ER, to determine whether the regulation affects the expression and/or phosphorylation...
24.
Mabuchi S, Ohmichi M, Nishio Y, Hayasaka T, Kimura A, Ohta T, et al.
J Biol Chem . 2004 Mar; 279(22):23477-85. PMID: 15026414
Whether or not inhibition of NFkappaB increases the efficacy of cisplatin in in vitro and in vivo ovarian cancer models was investigated. We compared the basal levels of phosphorylation of...
25.
Nakatsuji Y, Nishio Y, Tani N, Adachi K, Ohmichi M, Hisamoto K, et al.
Endocr J . 2004 Jan; 50(6):703-14. PMID: 14709841
The trophoblast, an important component of the mammalian placenta, has several essential biological roles in the maintenance of pregnancy. First, trophoblast cells must attach to the uterine endometrium, and then...
26.
Arimoto-Ishida E, Ohmichi M, Mabuchi S, Takahashi T, Ohshima C, Hayakawa J, et al.
Endocrinology . 2004 Jan; 145(4):2014-22. PMID: 14701673
The Forkhead family transcription factor FKHRL1 is an inducer of apoptosis in its unphosphorylated form and was recently reported to be a substrate of Akt kinase. We studied the roles...
27.
Mabuchi S, Ohmichi M, Kimura A, Ikebuchi Y, Hisamoto K, Arimoto-Ishida E, et al.
Endocrinology . 2003 Dec; 145(3):1302-13. PMID: 14645110
Although tamoxifen (TAM), which is widely used in the treatment of breast cancer, also has a beneficial effect on cisplatin-refractory ovarian cancer, the biological mechanism of this effect has remained...
28.
Ishiyama T, Sato K, Nishio Y, Miyaura N
Angew Chem Int Ed Engl . 2003 Nov; 42(43):5346-8. PMID: 14613172
No abstract available.
29.
Mabuchi S, Ohmichi M, Kimura A, Nishio Y, Arimoto-Ishida E, Yada-Hashimoto N, et al.
Endocrinology . 2003 Sep; 145(1):49-58. PMID: 14500571
The influence of postoperative estrogen replacement therapy on the sensitivity of ovarian cancer to paclitaxel remains elusive. We examined whether estrogen affects paclitaxel-induced apoptosis in the Caov-3 human ovarian cancer...
30.
Mabuchi S, Ohmichi M, Kimura A, Hisamoto K, Hayakawa J, Nishio Y, et al.
J Biol Chem . 2002 Jun; 277(36):33490-500. PMID: 12087097
We studied the roles of the phosphatidylinositol 3-kinase (PI-3K)-Akt-BAD cascade, ERK-BAD cascade, and Akt-Raf-1 cascade in the paclitaxel-resistant SW626 human ovarian cancer cell line, which lacks functional p53. Treatment of...